OR WAIT null SECS
© 2024 MJH Life Sciences™ and BioPharm International. All rights reserved.
Dual-sourcing and redundant manufacturing capabilities are crucial in a single-use supply chain strategy, but must be applied correctly.
As single-use systems (SUS) have increasingly been implemented in GMP biopharmaceutical production, supply-chain assurance for SUS materials, components, and assemblies has become even more important. Dual-sourcing and redundant manufacturing capabilities are crucial in a single-use supply chain strategy. However, these tenets of supply-chain management are often misapplied and undervalued, leading to potential risk that can result in delays or even stoppages in critical drug production.
Read this article in BioPharm International's Single-Use Systems 2019 eBook.
BioPharm International
eBook: Single-Use Systems
Vol. 32
June 2019
Pages: 10–13
When referring to this article, please cite it as T. Korwan and J. Harp, " New Strategies for Managing Single-Use Components," BioPharm International Single-Use Systems eBook (June 2019).